PAU18 Antibody

Shipped with Ice Packs
In Stock

Description

Clarification of Terminology

The term "PAU18" does not correspond to any documented antibody nomenclature in:

  • The Antibody Society’s therapeutic antibody database

  • Structural classifications of SARS-CoV-2 neutralizing antibodies

  • Lupus-related anti-ribosomal P protein antibody studies

  • Broad antibody characterization initiatives (e.g., YCharOS, Human Protein Atlas)

Possible reasons for the absence include:

  • Non-standard naming: PAU18 may be an internal project code or unpublished identifier.

  • Typographical error: Potential confusion with established antibodies (e.g., pembrolizumab, palivizumab) or ribosomal P protein antibodies (e.g., 9D5, 4H11) .

Relevant Antibody Research Context

While PAU18 is unverified, recent advancements in antibody discovery and characterization provide insights into similar agents:

Table 1: Key Antibody Classes and Applications

Antibody TypeTarget/FunctionExample AgentsClinical Relevance
Anti-P monoclonalRibosomal P proteins (C-terminal epitope)9D5, 4H11SLE diagnostics/therapeutics
SARS-CoV-2 neutralizingSpike protein RBD/ACE2 blockadeC102, C105, B1-182.1COVID-19 prevention/treatment
Checkpoint inhibitorsPD-1/CTLA-4Pembrolizumab, IpilimumabCancer immunotherapy

Methodological Advances in Antibody Development

Emerging technologies could accelerate PAU18-like antibody discovery:

  • Microfluidics-enabled ASC screening: Enables isolation of high-affinity antibodies (<1 pM) in 2 weeks .

  • Structural-guided engineering: Utilizes cryo-EM and X-ray crystallography to optimize epitope binding (e.g., SARS-CoV-2 antibodies) .

  • KO cell line validation: Critical for confirming specificity, as demonstrated in YCharOS studies .

Recommendations for Further Inquiry

To resolve the ambiguity around PAU18:

  1. Verify nomenclature with regulatory bodies (e.g., WHO’s INN, FDA Orange Book).

  2. Explore patent databases for preclinical candidates.

  3. Contact academic consortia (e.g., YCharOS, Human Protein Atlas) for unpublished data.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PAU18 antibody; YLL064C antibody; L0543 antibody; Seripauperin-18 antibody
Target Names
PAU18
Uniprot No.

Q&A

What is PAU18 and why is it significant for research?

PAU18 belongs to the PAU (seriPAUper) family of proteins in Saccharomyces cerevisiae, which are induced under anaerobic conditions and other stress factors. These proteins are part of the cell wall and play roles in adaptation to environmental stresses. Studying PAU18 using specific antibodies helps understand yeast stress responses, cell wall dynamics, and potential applications in biotechnology. The PAU18 Antibody (CSB-PA316558XA01SVG) is a polyclonal antibody raised in rabbits against recombinant Saccharomyces cerevisiae (strain ATCC 204508/S288c) PAU18 protein .

What are the optimal storage conditions for PAU18 antibodies?

PAU18 antibodies should be stored at -20°C or -80°C upon receipt to maintain integrity and activity. Repeated freeze-thaw cycles should be avoided as they can degrade antibody quality and reduce binding affinity. The antibody is typically supplied in a liquid form containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . For short-term use (less than one week), storage at 4°C is acceptable, but long-term storage requires freezing temperatures.

What applications are PAU18 antibodies validated for?

The PAU18 antibody has been validated for specific research applications including Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) . These techniques allow for both quantitative analysis and qualitative detection of PAU18 protein in yeast samples. The antibody's specificity for Saccharomyces cerevisiae (strain ATCC 204508/S288c) makes it suitable for research focusing on this particular yeast strain. Researchers should conduct validation tests when applying this antibody to other strains or modified experimental conditions.

How should I determine the appropriate dilution factors for PAU18 antibody applications?

Determining optimal dilution factors requires empirical testing. For Western blotting, begin with a 1:1000 dilution and adjust based on signal-to-noise ratio. For ELISA applications, a titration series starting from 1:500 to 1:10,000 is recommended to establish the optimal working concentration. Factors affecting optimal dilution include:

  • Sample preparation method

  • Protein expression levels

  • Detection system sensitivity

  • Background interference

Always include appropriate controls to validate specificity and reduce non-specific binding. Titration experiments should be systematically documented to establish reproducible protocols for future experiments.

How can I validate PAU18 antibody specificity in complex yeast protein extracts?

Validating antibody specificity is crucial for reliable results. Consider implementing these advanced validation approaches:

  • Knockout/knockdown controls: Compare wild-type yeast with PAU18 deletion strains to confirm specificity

  • Pre-absorption testing: Pre-incubate the antibody with purified recombinant PAU18 protein before immunoblotting to demonstrate binding specificity

  • Mass spectrometry confirmation: Perform immunoprecipitation followed by mass spectrometry to identify all proteins captured by the antibody

  • Cross-reactivity assessment: Test against other PAU family proteins to evaluate potential cross-reactivity

A systematic validation approach should include quantitative assessment of binding affinity and specificity metrics. Document all validation experiments thoroughly to support publication requirements and reproducibility.

What are the best approaches for troubleshooting inconsistent PAU18 antibody performance?

When experiencing inconsistent results with PAU18 antibodies, consider these methodological approaches:

  • Sample preparation optimization:

    • Test different lysis buffers to improve protein extraction

    • Evaluate the need for protease inhibitors to prevent degradation

    • Consider native vs. denaturing conditions based on epitope accessibility

  • Protocol modifications:

    • Adjust blocking reagents to reduce background

    • Optimize incubation times and temperatures

    • Test multiple detection systems

  • Antibody handling:

    • Avoid repeated freeze-thaw cycles

    • Consider aliquoting the antibody upon receipt

    • Verify storage conditions were maintained

  • Control implementation:

    • Include positive and negative controls in each experiment

    • Use loading controls appropriate for your experimental conditions

Systematically document all troubleshooting steps and outcomes to identify the critical variables affecting performance.

How can I optimize immunoprecipitation protocols for PAU18 protein complexes?

Optimizing immunoprecipitation (IP) for PAU18 requires careful consideration of multiple factors:

  • Lysis conditions:

    • Use gentle lysis buffers to preserve protein-protein interactions

    • Consider crosslinking to stabilize transient interactions

    • Optimize salt concentration to maintain specific interactions while reducing non-specific binding

  • Antibody coupling:

    • Direct coupling to beads may improve efficiency

    • Determine optimal antibody-to-bead ratio (typically 2-10 μg antibody per 50 μl bead slurry)

    • Consider orientation-specific coupling techniques to maximize epitope accessibility

  • Washing stringency:

    • Develop a gradient washing strategy with decreasing salt concentrations

    • Monitor protein retention after each washing step

    • Balance specificity (high stringency) with sensitivity (low stringency)

  • Elution methods:

    • Compare different elution strategies (pH, competitive, denaturing)

    • Evaluate elution efficiency through Western blotting

    • Consider sequential elution steps for comprehensive recovery

Careful optimization of each step will improve the quality of data obtained from IP experiments with PAU18 antibodies.

What experimental designs are most effective for studying PAU18 expression under stress conditions?

When investigating PAU18 expression under various stress conditions, consider these experimental design principles:

  • Time-course analysis:

    • Sample at multiple time points following stress induction

    • Include early time points (15, 30, 60 minutes) and extended periods (2, 4, 8, 24 hours)

    • Normalize expression to non-stressed controls at each time point

  • Dose-response relationships:

    • Test multiple intensities of the stress factor

    • Include sub-threshold and saturation conditions

    • Determine EC50 values for specific stress responses

  • Combinatorial stress conditions:

    • Investigate synergistic or antagonistic effects of multiple stressors

    • Design factorial experiments to identify interactions

    • Apply statistical models appropriate for multi-factorial designs

  • Single-cell vs. population-level analysis:

    • Consider heterogeneity in stress responses

    • Implement flow cytometry or microscopy for single-cell resolution

    • Compare with bulk measurements to identify population dynamics

Stress ConditionSampling TimepointsControl ConditionKey Measurements
Anaerobic shift0, 0.5, 1, 2, 4, 8, 24 hrsAerobic growthPAU18 protein levels, cell viability
Ethanol stress0, 0.5, 1, 2, 4, 8, 24 hrsNo ethanolPAU18 localization, stress response genes
Temperature shift0, 0.5, 1, 2, 4, 8, 24 hrsOptimal temperatureMembrane integrity, PAU18 expression
Nutrient limitation0, 2, 4, 8, 24, 48 hrsComplete mediaGrowth rate, PAU18 distribution

How should I interpret contradictory results when comparing PAU18 protein levels and gene expression data?

Discrepancies between protein abundance and transcript levels are common in biological systems. When facing contradictory results:

  • Consider post-transcriptional regulation:

    • Investigate mRNA stability and half-life

    • Examine translation efficiency through polysome profiling

    • Assess potential microRNA regulation

  • Evaluate protein stability and turnover:

    • Perform pulse-chase experiments to determine protein half-life

    • Investigate ubiquitination and proteasomal degradation

    • Examine autophagy contribution to protein turnover

  • Analyze temporal dynamics:

    • Ensure appropriate sampling resolution to capture rapid changes

    • Consider time delays between transcription and translation

    • Implement mathematical models to describe relationship dynamics

  • Technical considerations:

    • Validate antibody performance under the specific experimental conditions

    • Assess the dynamic range and limits of detection for both methods

    • Implement alternative orthogonal approaches for confirmation

Rigorous data analysis and appropriate statistical methods should be applied to distinguish biological variation from technical artifacts.

What are the best approaches for quantifying PAU18 localization changes during stress response?

Analyzing PAU18 subcellular localization requires sophisticated imaging and fractionation approaches:

  • Immunofluorescence optimization:

    • Fixation method selection (formaldehyde vs. methanol)

    • Permeabilization optimization for yeast cell wall

    • Antibody concentration titration for optimal signal-to-noise ratio

    • Z-stack acquisition for complete cellular coverage

  • Subcellular fractionation:

    • Implement differential centrifugation protocols

    • Validate fraction purity with compartment-specific markers

    • Quantify PAU18 distribution across fractions via Western blotting

    • Compare native versus stress-induced conditions

  • Live-cell imaging approaches:

    • Create fluorescent protein fusions (if appropriate)

    • Validate functionality of tagged proteins

    • Implement time-lapse microscopy with appropriate temporal resolution

    • Consider photobleaching approaches to assess protein dynamics

  • Quantification methods:

    • Apply automated image analysis algorithms

    • Implement colocalization analysis with known markers

    • Develop quantitative metrics for distribution patterns

    • Apply appropriate statistical tests for comparative analysis

How can I integrate PAU18 antibody-based approaches with other omics techniques?

Modern research benefits from multi-omics integration. Consider these approaches:

  • Integration with proteomics:

    • Combine immunoprecipitation with mass spectrometry (IP-MS)

    • Identify PAU18 interactome changes under different conditions

    • Validate key interactions through reciprocal IP or proximity labeling

  • Correlation with transcriptomics:

    • Compare PAU18 protein levels with RNA-seq data

    • Identify co-regulated gene clusters

    • Implement network analysis to place PAU18 in regulatory pathways

  • Complementation with functional genomics:

    • Screen for genetic interactions using synthetic genetic arrays

    • Evaluate phenotypic effects of PAU18 manipulation

    • Correlate antibody-based measurements with functional outcomes

  • Integration with structural biology:

    • Use antibody epitope mapping to inform structural studies

    • Implement antibody-based techniques for conformational analysis

    • Correlate structural changes with functional outcomes

What considerations are important when using PAU18 antibodies in chromatin immunoprecipitation (ChIP) experiments?

While PAU18 is not a typical DNA-binding protein, if investigating potential chromatin associations:

  • Crosslinking optimization:

    • Test different crosslinking agents (formaldehyde, DSG, EGS)

    • Optimize crosslinking time and temperature

    • Consider dual crosslinking for enhancing weak or transient interactions

  • Sonication parameters:

    • Develop a sonication protocol yielding 200-500 bp fragments

    • Verify fragment size distribution through gel electrophoresis

    • Ensure consistent fragmentation across samples

  • IP condition modifications:

    • Adjust salt concentrations to minimize non-specific chromatin binding

    • Implement stringent washing procedures

    • Include appropriate controls (IgG, input, non-enriched regions)

  • Data analysis considerations:

    • Apply appropriate peak calling algorithms

    • Implement controls for false discovery rate estimation

    • Validate findings with orthogonal methods (e.g., reporter assays)

How can computational approaches enhance PAU18 antibody-based research?

Computational methods can significantly enhance antibody-based research:

  • Epitope prediction and analysis:

    • Implement bioinformatic tools to predict PAU18 epitopes

    • Assess epitope conservation across related proteins

    • Correlate epitope structure with antibody performance

  • Image analysis automation:

    • Develop machine learning algorithms for image segmentation

    • Implement automated quantification workflows

    • Apply statistical methods for robust comparisons

  • Network analysis:

    • Integrate PAU18 interaction data into broader networks

    • Identify functional modules and pathways

    • Predict functional consequences of perturbations

  • Molecular dynamics simulations:

    • Model antibody-antigen interactions

    • Predict effects of mutations on binding affinity

    • Guide experimental design for structure-function studies

What emerging technologies might enhance PAU18 antibody research?

Research with PAU18 antibodies can benefit from these emerging technologies:

  • Single-cell proteomics:

    • Apply microfluidic antibody-based methods for single-cell analysis

    • Correlate PAU18 levels with cell-to-cell variability in stress response

    • Identify rare cell populations with unique PAU18 expression patterns

  • Proximity labeling techniques:

    • Implement BioID or APEX2 fusion approaches

    • Map the spatial environment of PAU18 in different conditions

    • Identify transient interaction partners

  • Super-resolution microscopy:

    • Apply STORM, PALM, or STED for nanoscale localization

    • Resolve PAU18 distribution within yeast cell wall subdomains

    • Correlate localization patterns with functional outcomes

  • Antibody engineering:

    • Develop single-domain antibodies for improved penetration

    • Create bifunctional antibody constructs for specialized applications

    • Engineer antibody fragments for intracellular expression

How might PAU18 antibody research contribute to understanding broader stress response mechanisms?

PAU18 research has implications for fundamental biological understanding:

  • Evolutionary conservation of stress responses:

    • Compare PAU18 function with related proteins in other yeast species

    • Identify conserved mechanistic principles across species

    • Trace the evolutionary history of stress response mechanisms

  • Systems biology of stress adaptation:

    • Place PAU18 within the broader stress response network

    • Identify regulatory hubs and control points

    • Model dynamic responses and adaptation processes

  • Cell wall remodeling mechanisms:

    • Elucidate PAU18's role in cell wall structure during stress

    • Examine coordination between PAU family members

    • Investigate implications for antifungal resistance

  • Biotechnological applications:

    • Explore potential for engineering stress-resistant yeast strains

    • Develop biosensors based on PAU18 expression

    • Apply knowledge to industrial fermentation optimization

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.